“EVALUATION OF CITALOPRAM AFFECTED THE GENERALIZED ANXIETY DISORDER PARTICIPANTS’ QUALITY OF LIFE”, Int. Res. J. Pharm., vol. 14, no. 11, pp. 21–25, Nov. 2023, doi: 10.56802/kedfgd52.